Antidepressants Question Bank

Question 1:

Which of the following drugs is a Selective Serotonin Reuptake Inhibitor (SSRI)?

A. Venlafaxine
B. Bupropion
C. Fluoxetine
D. Amitriptyline
E. Moclobemide

---

Question 2:

Which antidepressant is known for inhibiting both norepinephrine and dopamine reuptake?

A. Sertraline
B. Duloxetine
C. Desipramine
D. Bupropion
E. Trazodone

---

Question 3:

Which class of antidepressants includes drugs that irreversibly inhibit monoamine oxidase?

A. SSRIs
B. SNRIs
C. TCAs
D. MAOIs
E. SARIs

---

Question 4:

Which antidepressant is specifically noted for its use as a sleep aid due to its sedative effects?

A. Citalopram
B. Bupropion
C. Venlafaxine
D. Trazodone
E. Fluoxetine

---

Question 5:

Which antidepressant is a reversible inhibitor of monoamine oxidase A (RIMA)?

A. Phenelzine
B. Moclobemide
C. Tranylcypromine
D. Nortriptyline
E. Amitriptyline

---

Question 6:

Which of the following drugs is a Selective Serotonin Reuptake Inhibitor (SSRI)?

A. Venlafaxine
B. Bupropion
C. Fluoxetine
D. Amitriptyline
E. Moclobemide

---

Question 7:

Which antidepressant is known for inhibiting both norepinephrine and dopamine reuptake?

A. Sertraline
B. Duloxetine
C. Desipramine
D. Bupropion
E. Trazodone

---

Question 8:

Which class of antidepressants includes drugs that irreversibly inhibit monoamine oxidase?

A. SSRIs
B. SNRIs
C. TCAs
D. MAOIs
E. SARIs

---

Question 9:

Which antidepressant is specifically noted for its use as a sleep aid due to its sedative effects?

A. Citalopram
B. Bupropion
C. Venlafaxine
D. Trazodone
E. Fluoxetine

---

Question 10:

Which antidepressant is a reversible inhibitor of monoamine oxidase A (RIMA)?

A. Phenelzine
B. Moclobemide
C. Tranylcypromine
D. Nortriptyline
E. Amitriptyline

---

Question 11:

Which of the following is NOT a common side effect of SSRIs?

A. Nausea
B. Weight gain
C. Insomnia
D. Hypertension
E. Sexual dysfunction

---

Question 12:

What is a potential risk when abruptly discontinuing SSRI treatment?

A. Severe liver damage
B. Serotonin syndrome
C. SSRI discontinuation syndrome
D. Hypothyroidism
E. Kidney failure

---

Question 13:

Which SSRI is known for having a particularly long half-life, which can be beneficial in reducing withdrawal symptoms?

A. Paroxetine
B. Sertraline
C. Citalopram
D. Fluoxetine
E. Escitalopram

---

Question 14:

In addition to depression, SSRIs are commonly prescribed for which of the following conditions?

A. Schizophrenia
B. Bipolar disorder
C. Obsessive-compulsive disorder (OCD)
D. Alzheimer’s disease
E. Parkinson’s disease

---

Question 15:

How do SSRIs typically affect sleep patterns initially?

A. They improve sleep immediately
B. They have no effect on sleep
C. They can cause insomnia or disturbed sleep
D. They cause immediate deep sleep
E. They lead to sleep apnea

---

Question 16:

Which neurotransmitter system is most directly targeted by SSRIs?

A. Dopamine
B. Norepinephrine
C. Glutamate
D. Serotonin
E. Acetylcholine

---

Question 17:

Which SSRI is known for its stimulating effects and can cause insomnia and agitation?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 18:

Which SSRI is more likely to cause sedation and weight gain?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 19

Which SSRI is associated with an increased risk of gastrointestinal bleeding when combined with NSAIDs?

A) Fluoxetine
B) Sertraline
C) Paroxetine
D) Citalopram
E) Escitalopram

---

Question 20

Which SSRI is associated with a prolonged QT interval, increasing the risk of cardiac arrhythmias?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Fluvoxamine

---

Question 21

Which SSRI is known for causing significant gastrointestinal disturbances, including nausea and vomiting?

A) Sertraline
B) Paroxetine
C) Fluvoxamine
D) Citalopram
E) Escitalopram

---

Question 22

Which SSRI is often preferred for patients with both depression and anxiety due to its broad efficacy?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 23

Which SSRI is known for having the longest half-life, which helps reduce withdrawal symptoms?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 24

Which SSRI should be used with caution in elderly patients due to the risk of hyponatremia?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 25

Which SSRI is often chosen for patients who have experienced sexual side effects with other SSRIs due to its lower incidence of such side effects?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 26

Which SSRI has a high risk of drug interactions due to its potent inhibition of the CYP2D6 enzyme?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 27

Which SSRI is commonly prescribed for treating major depressive disorder in adolescents?

A) Sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram
E) Escitalopram

---

Question 28:

Which of the following drug combinations is most likely to cause serotonin syndrome?

A. Fluoxetine and Ibuprofen
B. Venlafaxine and Acetaminophen
C. Sertraline and Tramadol
D. Paroxetine and Amoxicillin
E. Citalopram and Omeprazole

---

Question 29:

Which of the following symptoms is NOT typically associated with serotonin syndrome?

A. Hyperthermia
B. Muscle rigidity
C. Hypertension
D. Bradycardia
E. Agitation

---

Question 30:

Which of the following is a common early sign of serotonin syndrome?

A. Severe headache
B. Sweating and shivering
C. Persistent cough
D. Yellowing of the skin
E. Difficulty swallowing

---

Question 31:

What is the primary mechanism of action of Monoamine Oxidase Inhibitors (MAOIs) leading to serotonin syndrome?

A. Inhibition of serotonin reuptake
B. Inhibition of monoamine oxidase enzymes
C. Blocking of serotonin receptors
D. Enhancing dopamine release
E. Inhibition of norepinephrine reuptake

---

Question 32:

Which of the following is NOT a known risk factor for developing serotonin syndrome?

A. Combining SSRIs with MAOIs
B. Overdose of an SSRI
C. Combining triptans with SSRIs
D. Using St. John’s Wort with SNRIs
E. Taking SSRIs with acetaminophen

---

Question 33:

Which combination of medications is least likely to cause serotonin syndrome?

A. Fluoxetine and Linezolid
B. Citalopram and St. John’s Wort
C. Sertraline and Sumatriptan
D. Escitalopram and Tramadol
E. Paroxetine and Acetaminophen

---

Question 34:

Which combination of drugs would most likely lead to an increased risk of serotonin syndrome when used together?

A. Amitriptyline and Ibuprofen
B. Bupropion and Metformin
C. Fluoxetine and Selegiline
D. Venlafaxine and Lisinopril
E. Duloxetine and Loratadine

---

Question 35:

Which of the following drug combinations should be avoided due to a high risk of serotonin syndrome?

A. Escitalopram and Aspirin
B. Sertraline and Warfarin
C. Venlafaxine and Linezolid
D. Duloxetine and Ibuprofen
E. Paroxetine and Simvastatin

---

Question 36:

A patient has been on an SSRI for several years and is considering stopping the medication abruptly. Which SSRI is likely to have the mildest discontinuation symptoms due to its long half-life?

A. Sertraline
B. Paroxetine
C. Citalopram
D. Escitalopram
E. Fluoxetine

---

Question 37:

A patient is concerned about severe discontinuation symptoms if they abruptly stop taking their SSRI. Which SSRI is most likely to cause severe discontinuation symptoms due to its short half-life?

A. Sertraline
B. Fluoxetine
C. Citalopram
D. Paroxetine
E. Escitalopram

---

Question 38 Which TCA is commonly used for migraine prophylaxis?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 39 Which TCA is specifically indicated for treating obsessive-compulsive disorder (OCD)?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 40 Which TCA is more likely to cause sedation due to histamine H1 receptor antagonism?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 41 What is the primary mechanism of action for TCAs?

A) Inhibition of dopamine reuptake
B) Inhibition of norepinephrine and serotonin reuptake
C) Stimulation of GABA receptors
D) Inhibition of acetylcholine release
E) Blockade of sodium channels

---

Question 42 Which TCA is commonly used to treat enuresis (bedwetting) in children?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 43 Which of the following TCAs is more effective at inhibiting norepinephrine reuptake?

A) Amitriptyline
B) Imipramine
C) Clomipramine
D) Desipramine
E) Doxepin

---

Question 44 What should be used to manage TCA overdose and its cardiotoxic effects?

A) Activated Charcoal
B) Sodium Bicarbonate
C) Benzodiazepines
D) Supportive Care
E) All of the above

---

Question 45 Which TCA is commonly used for chronic pain and neuropathic pain?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 46 Which TCA has a higher likelihood of causing cardiotoxicity, especially in overdose?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 47 What is the major therapeutic use of imipramine besides depression?

A) Anxiety disorders
B) Obsessive-compulsive disorder (OCD)
C) Enuresis (bedwetting) in children
D) Chronic pain
E) Migraine prophylaxis

---

Question 48 Which TCA is often preferred due to its lower incidence of anticholinergic side effects?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Desipramine

---

Question 49 Which receptor antagonism by TCAs is primarily responsible for causing orthostatic hypotension?

A) Histamine H1 receptors
B) Muscarinic acetylcholine receptors
C) Alpha-1 adrenergic receptors
D) Serotonin receptors
E) Dopamine receptors

---

Question 50 Which TCA is most likely to be used in the treatment of major depressive disorder in elderly patients due to its relatively favorable side effect profile?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 51 Which TCA is specifically indicated for treating anxiety disorders?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Doxepin

---

Question 52 Which TCA has the highest risk of causing weight gain with prolonged use?

A) Nortriptyline
B) Imipramine
C) Amitriptyline
D) Clomipramine
E) Desipramine

---

Question 53 What is the primary mechanism of action for Monoamine Oxidase Inhibitors (MAOIs)?

A) Inhibition of serotonin reuptake
B) Inhibition of monoamine oxidase enzyme
C) Inhibition of norepinephrine reuptake
D) Stimulation of dopamine release
E) Blockade of histamine receptors

---

Question 54 Which type of MAOI is reversible and specifically inhibits MAO-A?

A) Phenelzine
B) Tranylcypromine
C) Selegiline
D) Moclobemide
E) Rasagiline

---

Question 55 Which of the following MAOIs is used to manage symptoms of Parkinson’s disease?

A) Phenelzine
B) Tranylcypromine
C) Selegiline
D) Moclobemide
E) Isocarboxazid

---

Question 56 What dietary component must patients avoid while taking MAOIs to prevent hypertensive crises?

A) Glucose
B) Sodium
C) Tyramine
D) Potassium
E) Magnesium

---

Question 57 Which of the following is a common side effect of MAOIs?

A) Hypertensive crisis
B) Hyperglycemia
C) Bradycardia
D) Hypercalcemia
E) Hyperlipidemia

---

Question 58 Which MAOI is an example of a non-selective irreversible inhibitor?

A) Phenelzine
B) Moclobemide
C) Rasagiline
D) Selegiline
E) Desipramine

---

Question 59 Which of the following symptoms is indicative of an MAOI overdose?

A) Hypoglycemia
B) Severe headache
C) Weight loss
D) Slow heart rate
E) Drowsiness

---

Question 60 What should be administered to manage the cardiotoxic effects of an MAOI overdose?

A) Insulin
B) Activated Charcoal
C) Vitamin D
D) Antidepressants
E) Calcium supplements

---

Question 61 Which of the following is a contraindication for using MAOIs?

A) Diabetes
B) Pheochromocytoma
C) Asthma
D) Hyperthyroidism
E) Chronic bronchitis

---

Question 62 A 45-year-old female patient is prescribed venlafaxine for generalized anxiety disorder. She is concerned about potential side effects, especially related to her blood pressure. As a pharmacist, what should you inform her about the dose-dependent effects of venlafaxine?

A) Venlafaxine only affects serotonin levels and does not impact blood pressure
B) Hypertension is a dose-dependent side effect, particularly at doses above 225 mg
C) Venlafaxine causes hypotension, especially at higher doses
D) There is no risk of blood pressure changes with venlafaxine
E) Hypertension occurs regardless of the dose

---

Question 63 A 38-year-old male patient is taking desvenlafaxine for major depressive disorder. He asks how this medication works. What is the correct explanation of its mechanism of action?

A) Inhibits the reuptake of serotonin and dopamine
B) Inhibits the reuptake of serotonin and norepinephrine
C) Inhibits the reuptake of dopamine and norepinephrine
D) Increases the release of serotonin and norepinephrine
E) Blocks the action of acetylcholine

---

Question 64 A 60-year-old female patient with diabetic peripheral neuropathy is prescribed duloxetine. She also has knee osteoarthritis. What additional benefit might she experience from this medication?

A) Reduced risk of gastrointestinal bleeding
B) Improved cardiovascular health
C) Pain relief for knee osteoarthritis
D) Enhanced cognitive function
E) Increased bone density

---

Question 65 A 55-year-old male patient taking venlafaxine for social anxiety disorder reports experiencing nausea and constipation after starting the medication. As a pharmacist, what management strategies can you suggest?

A) Discontinue the medication immediately
B) Increase fluid intake, consume fiber-rich foods, and exercise
C) Take the medication with a high-protein meal
D) Switch to a different medication
E) Reduce the dose of venlafaxine

---

Question 66 A 48-year-old female patient is taking duloxetine and is concerned about potential serious side effects. What serious side effects should the pharmacist inform her about?

A) Hyperglycemia and increased appetite
B) Dose-dependent hypertension, increased heart rate, and risk of bleeding
C) Hypotension and bradycardia
D) Weight loss and increased libido
E) Hair loss and skin rash

---

Question 67 A 35-year-old female patient with major depressive disorder also struggles with significant weight loss and anorexia. Her doctor is considering prescribing an antidepressant that might help her gain weight. Which medication is most appropriate for this patient, and why?

A) Fluoxetine
B) Sertraline
C) Bupropion
D) Mirtazapine
E) Venlafaxine

---

Question 68 A 42-year-old male patient with depression is concerned about experiencing nausea and vomiting with his new antidepressant. Which antidepressant is least likely to cause these side effects, and what is the mechanism behind this?

A) Citalopram
B) Escitalopram
C) Mirtazapine
D) Fluoxetine
E) Duloxetine

---

Question 69 A 65-year-old male patient with major depressive disorder and insomnia is prescribed trazodone. He asks how this medication will help with his insomnia. What should you explain about trazodone’s mechanism of action related to sleep?

A) It inhibits dopamine reuptake
B) It blocks histamine H1 receptors, causing sedation and drowsiness
C) It enhances GABA transmission
D) It stimulates melatonin receptors
E) It acts as an MAO inhibitor

---

Question 70 A 70-year-old female patient with dementia exhibits symptoms of sundown syndrome, including agitation and restlessness in the late afternoon. Her doctor prescribes trazodone off-label for this condition. What benefits of trazodone can help manage her symptoms?

A) Increases norepinephrine levels to improve mood
B) Reduces anxiety and agitation through 5-HT2A receptor antagonism
C) Enhances cognitive function by stimulating dopamine receptors
D) Prevents serotonin reuptake, which decreases irritability
E) Blocks GABA receptors to reduce confusion

---

Question 71 A 50-year-old male patient with major depressive disorder and chronic pain is prescribed trazodone. As a pharmacist, what common side effects should you inform him about?

A) Weight loss, insomnia, and dry mouth
B) Sedation, dizziness, and dry mouth
C) Increased energy, nausea, and blurred vision
D) Hyperactivity, headache, and diarrhea
E) Weight gain, insomnia, and hypertension

---

Question 72 A 60-year-old male patient with anxiety and insomnia is concerned about the potential for orthostatic hypotension with trazodone. What specific receptor antagonism by trazodone is responsible for this side effect?

A) 5-HT2A receptor antagonism
B) Alpha-1 adrenergic receptor antagonism
C) Histamine H1 receptor antagonism
D) 5-HT1A receptor agonism
E) Serotonin reuptake inhibition

---

Question 73 A 35-year-old female patient with major depressive disorder is starting treatment with vilazodone. She asks how this medication might improve her mood and anxiety. What should you explain about vilazodone’s mechanism of action?

A) It enhances dopamine transmission
B) It acts as a partial agonist at 5-HT1A receptors and inhibits serotonin reuptake
C) It blocks norepinephrine reuptake and inhibits MAO
D) It stimulates GABA receptors and inhibits serotonin reuptake
E) It antagonizes histamine H1 receptors and increases serotonin release

---

Question 74 A 58-year-old male patient is prescribed vortioxetine for major depressive disorder. He is curious about its receptor actions. What should you inform him about the specific receptor profile of vortioxetine?

A) It antagonizes 5-HT3, 5-HT1D, and 5-HT7 receptors and acts as an agonist at 5-HT1A receptors
B) It inhibits dopamine reuptake and stimulates 5-HT2A receptors
C) It blocks histamine H1 receptors and enhances norepinephrine release
D) It inhibits MAO-A and MAO-B enzymes and acts as a GABA agonist
E) It antagonizes alpha-1 adrenergic receptors and stimulates serotonin release

---

Question 75 A 70-year-old female patient taking trazodone for insomnia reports experiencing dizziness and a significant drop in blood pressure upon standing. What is the most likely cause of these symptoms?

A) Antagonism of 5-HT1A receptors
B) Agonism of 5-HT1B receptors
C) Antagonism of alpha-1 adrenergic receptors
D) Agonism of histamine H1 receptors
E) Inhibition of serotonin reuptake

---

Question 76 A 40-year-old male patient with major depressive disorder has been taking sertraline for six months. He reports experiencing sexual dysfunction, including decreased libido and difficulty achieving orgasm, which is affecting his relationship. He is concerned about continuing the medication due to these side effects. As a pharmacist, what alternative antidepressant might you suggest discussing with his healthcare provider, and why?

A) Fluoxetine
B) Venlafaxine
C) Bupropion
D) Trazodone
E) Paroxetine

---

Question 77 A 35-year-old male patient with major depressive disorder and a history of seasonal affective disorder (SAD) is prescribed bupropion. As a pharmacist, what should you inform him about the mechanism of action of bupropion?

A) Inhibits serotonin reuptake
B) Inhibits norepinephrine and dopamine reuptake
C) Inhibits GABA reuptake
D) Inhibits acetylcholine reuptake
E) Inhibits MAO-A and MAO-B

---

Question 78 A 45-year-old female patient is looking for an antidepressant with a lower risk of sexual dysfunction. She is currently experiencing these side effects with her SSRI. Which antidepressant might be a suitable alternative for her?

A) Fluoxetine
B) Sertraline
C) Venlafaxine
D) Bupropion
E) Paroxetine

---

Question 79 A 60-year-old male patient with major depressive disorder is concerned about potential weight gain from antidepressants. Which antidepressant might be beneficial for him due to its weight neutrality and potential for weight loss?

A) Fluoxetine
B) Sertraline
C) Bupropion
D) Trazodone
E) Paroxetine

---

Question 80 A 50-year-old female patient with a history of eating disorders and depression is prescribed bupropion. As a pharmacist, what contraindication should you discuss with her healthcare provider?

A) Risk of liver toxicity
B) Increased risk of gastrointestinal bleeding
C) Increased risk of seizures
D) Increased risk of hypotension
E) Increased risk of kidney stones

---

Question 81 A 40-year-old male patient with major depressive disorder and smoking addiction is prescribed bupropion as part of his smoking cessation program. What benefit of bupropion should you inform him about regarding smoking cessation?

A) Reduces nicotine cravings and withdrawal symptoms
B) Increases the metabolism of nicotine
C) Acts as a nicotine substitute
D) Decreases the absorption of nicotine
E) Prevents the breakdown of nicotine in the liver

---

Question 82 A 55-year-old male patient with hypertension is prescribed bupropion for major depressive disorder. What serious side effect related to blood pressure should you monitor for?

A) Hypotension
B) Orthostatic hypotension
C) Hypertension
D) Bradycardia
E) Tachycardia

Please read questions from the chapter as well.

*** End of Chapter ***